The additional liquidity will support both the continued development of Trinity Biotech’s innovative continuous glucose monitoring (CGM) technology and the Company Trinity Biotech’s patented ...

Diabetes CGM Developments We continue to progress ... Act”), including but not limited to statements related to Trinity Biotech’s cash position, financial resources and potential for future ...

Diabetes CGM Developments We continue to progress ... Act"), including but not limited to statements related to Trinity Biotech's cash position, financial resources and potential for future ...

We continue to progress the development of our next generation continuous glucose monitoring ("CGM”) solution for diabetes management ... including but not limited to statements related to Trinity ...

Diabetes CGM Developments We continue to progress the development ... Act of 1995 (the “Reform Act”), including but not limited to statements related to Trinity Biotech’s cash position, financial ...

DUBLIN, May 15, 2025 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics, including wearable ...

TRINITY BIOTECH ($TRIB) is expected to release its quarterly earnings data on Thursday, May 22nd before market open, per Finnhub. Analysts are expecting revenue of ...

Bray-based company says orders for HIV tests have rebounded since first quarter The Trinity Biotech facility in Bray, Co Wicklow The uncertainty caused by US president Donald Trump’s tariffs ...

Trinity Biotech plc acquires, together with its subsidiaries, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC ...